Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity and Wyeth Expand Software Licensing Deal

NEW YORK, Feb. 3 (GenomeWeb News) - Wyeth Pharmaceuticals and Ingenuity Systems have expanded a license agreement between the companies pertaining to Ingenuity's Pathways Analysis software, the companies said today.


Wyeth's researchers "downstream in the pharmaceutical value chain" would gain access to the software, Ingenuity CEO Jake Leschly said in the statement.


Financial terms of the expanded agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more